Lifeline Scientific Company Profile (LON:LSIC)

About Lifeline Scientific (LON:LSIC)

Lifeline Scientific logoLifeline Scientific, Inc. is a developer of products and services for cell, tissue and organ transplantation. The Company is engaged in the business of delivering a portfolio of related technologies, which include devices, solutions and protocols designed to maximize the use and availability of organs, tissues and cells. Its business units include Organ Recovery Systems and Tissue Testing Technologies (T3). Organ Recovery Systems is the transplant community's provider of products and services for donor organ recovery, preservation and transport. T3 is a cryobiology research laboratory focused on developing approaches to preserve, transport, and evaluate biological living materials for transplantation, and other clinical and research applications. Its products include LifePort Kidney Transporter, LifePort Liver Transporter, Vasosol, Universal SealRing Cannula and LifePort WorkStation. It also offers SPS-1, a Static Preservation Solution and KPS-1, a Kidney Perfusion Solution.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: N/A
  • Symbol: LON:LSIC
  • CUSIP: N/A
  • Web: www.lifeline-scientific.com/
Average Prices:
  • 52 Week Range: GBX 175 - GBX 320
P/E:
  • Trailing P/E Ratio:
  • P/E Growth:
Profitability:
  • Net Margins: 10.65%
  • Return on Equity: 10.61%
  • Return on Assets: 9.10%
Misc:
  • Average Volume: 4,679 shs.
 
Frequently Asked Questions for Lifeline Scientific (LON:LSIC)

What is Lifeline Scientific's stock symbol?

Lifeline Scientific trades on the London Stock Exchange (LON) under the ticker symbol "LSIC."

Who are some of Lifeline Scientific's key competitors?

How do I buy Lifeline Scientific stock?

Shares of Lifeline Scientific and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Lifeline Scientific's stock price today?

One share of Lifeline Scientific stock can currently be purchased for approximately GBX 308.50.


MarketBeat Community Rating for Lifeline Scientific (LON LSIC)
Community Ranking:  4.3 out of 5 (   )
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  38
MarketBeat's community ratings are surveys of what our community members think about Lifeline Scientific and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Lifeline Scientific (LON:LSIC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Lifeline Scientific (LON:LSIC)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Lifeline Scientific (LON:LSIC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Lifeline Scientific (LON:LSIC)
Current Year EPS Consensus Estimate: $0.22 EPS

Dividends

Dividend History for Lifeline Scientific (LON:LSIC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Lifeline Scientific (LON:LSIC)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Lifeline Scientific (LON:LSIC)
Latest Headlines for Lifeline Scientific (LON:LSIC)
Source:

Social

Social activity is not available for this stock.

Chart

Lifeline Scientific (LSIC) Chart for Wednesday, July, 26, 2017

This page was last updated on 7/26/2017 by MarketBeat.com Staff